Rexahn Pharmaceuticals, Inc. (RNN)

0.40
+0.009 (+2.679%)
Exchange
ASE
Day Range
0.331 - 0.350
52 Week Range
0.260 - 0.850
Open
0.331
Avg. Vol
450,408
Market Cap
62.36M
Short ratio
2.800
PEG Ratio
0.000
Earnings Share
-0.077
Bid
0.340
Book Value
0.098
EPS Current Year Estimate
-0.090
EPS Estimate Next Year
-0.050
Change from Year Low
0.085
Change from Year High
-0.505
Price Target 1 Year
2.830

Complete Profile

Name Rexahn Pharmaceuticals, Inc.
Sector Healthcare
Industry Biotechnology
Address

Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road
Suite 455
Rockville, MD 20850
United States - Map
Phone: 240-268-5300
Fax: 240-268-5310
Website: http://www.rexahn.com

Employees 22
Executives Dr. Peter D. Suzdak Ph.D.
Chief Exec. Officer and Director


Dr. Chang H. Ahn Ph.D.
Founder Chairman Emeritus and Director


Dr. Tae Heum Jeong D. Mgt.
Chief Financial Officer Sr. VP and Sec.


Dr. Ely Benaim M.D.
Chief Medical Officer


Dr. Reza Mazhari Ph.D.
VP of Translational Medicine


Holders
  • Vanguard Total Stock Market Index Fund
  • Vanguard Extended Market Index Fund
  • Spartan Extended Market Index Fund
  • Spartan Total Market Index Fund
  • Vanguard Balanced Index Fund
  • Quantitative Master Series Tr-Extended Market Index Series
  • AQR Funds-AQR Small Cap Momentum Style Fd
  • Claymore ETF Tr-Wilshire Micro Cap ETF
  • Philadelphia Investment Partners New Generation Fd